Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
Open accessThe DOI matches its Crossref record; 121 of the 122 references it cites were found in a registry or an index.
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the latest term for steatotic liver disease associated with metabolic syndrome. MASLD is the most common cause of chronic liver disease and is the leading cause of liver-related morbidity and mortality. It is important that all stakeholders be involved in tackling the public health threat of obesity and obesity-related diseases, including MASLD. A simple and clear assessment and referral pathway using non-invasive tests is essential to ensure that patients with severe MASLD are identified and referred to specialist care, while patients with less severe disease remain in primary care, where they are best managed. While lifestyle intervention is the cornerstone of the management of patients with MASLD, cardiovascular disease risk must be properly assessed and managed because cardiovascular disease is the leading cause of mortality. No pharmacological agent has been approved for the treatment of MASLD, but novel anti-hyperglycemic drugs appear to have benefit. Medications used for the treatment of diabetes and other metabolic conditions may need to be adjusted as liver disease progresses to cirrhosis, especially decompensated cirrhosis. Based on non-invasive tests, the concepts of compensated advanced chronic liver disease and clinically significant portal hypertension provide a practical approach to stratifying patients according to the risk of liver-related complications and can help manage such patients. Finally, prevention and management of sarcopenia should be considered in the management of patients with MASLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The growing yearly prevalence of Metabolic Dysfunction–non-alcoholic fatty liver disease (MASLD) has emerged as a worldwide public health concern, driven by improved living conditions, evolving lifestyle habits, and the widespread occurrence of obesity, diabetes, and metabolic syndrome.1”
From The Impact of Omega-3 Fatty Acids on Triglyceride Levels in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-Analysis of Randomized Controlled Trials with Subgroup Analysis by Diabetes Status (2026) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This is because the clinical definition of MASLD, as previously noted, includes not only the presence of steatosis but also a cardiometabolic context [31,32,33], which cannot be fully reproduced in a monoculture of hepatocyte-like cells.”
From The HepG2 Cell Line as a Model for Studying Metabolic Dysfunction-Associated Steatotic Liver Disease (2026) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818 · cited 2×
“102 Of late, there is a growing interest in studies on the association between sarcopenia and MASLD.”
BackgroundEASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000066 · Cited by 4,347
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Cited by
Items 301–400 of 784
Román-Calleja, B. M., Ruiz‐Margáin, A., Duarte‐Rojo, A., Flores-Silva, F., Martinez-Cabrera, C. F., Gutierrez-Rosas, L. E., Valencia-Peña, B. A., Cantú-Brito, C. G., Chalasani, N., Aguilar-Salinas, C. A., et al. (2025) · Liver Transplantation · doi:10.1097/lvt.0000000000000767 · Cited by 5
The Impact of Liraglutide on Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease
So, J. E., Jeong, J., Hong, J. P., Kim, D. Y., Lee, J. S., Kim, M. N., Kim, B. K., Park, J. Y., Kim, D. Y., Lee, H. W., et al. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70134 · Cited by 3
Kamar, S. A., Attia, M. I., Alahmadi, H. A., Hamza, A. Y., Hendawy, N., El-Galil, T. I. A., Yousef, T. A., Al-Dakhil, A., Khedr, S. A., Eissa, A. H., et al. (2025) · Libyan Journal of Medicine · doi:10.1080/19932820.2025.2585617 · Cited by 4
Regulated necrosis at the crossroads of liver inflammation and cancer development
Vucur, M., Kondylis, V., Brož, P., & Luedde, T. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01147-8 · Cited by 7
Zacharia, G. S., Ashraf, M. H., Sosa, F., Jacob, A., & Patel, H. (2025) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v16.i4.110827 · Cited by 3
Fan, A., Zhang, J., & Ye, Q. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1706068 · Cited by 4
Alqahtani, S. A., AlMuhaidib, S., Raptis, D. A., Al-hamoudi, W., Reddy, K. R., Broering, D., Alghamdi, S. A., & Collaborative, T. O. (2025) · PLoS ONE · doi:10.1371/journal.pone.0338438 · Cited by 3
Barbhuiya, P. A., Ahmed, A., & Pathak, M. P. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107702 · Cited by 7
Iwasaki, S., Shirouchi, B., Okumura, M., Higuchi, M., Mitsuta, S., & YANAGITA, T. (2025) · ACS Nutrition Science · doi:10.1021/acsnutrsci.5c00023 · Cited by 4
Barr, B., Subramaniyan, I., Li, L., Levitt, D. E., & Gollahon, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010403 · Cited by 4
Li, X., Luo, W., Chen, K., & Peng, Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1717852 · Cited by 6
Cui, T., Guan, C., Song, K., & Yu, J. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2025.1623789 · Cited by 4
Narem, R. S. R., Mathakala, V., Sallabathula, S. T., Peddiboyina, V., & Palempalli, U. M. D. (2026) · BMC Gastroenterology · doi:10.1186/s12876-026-04618-7 · Cited by 5
Psoriasis beyond the skin: systemic inflammation as a bridge to metabolic and hepatic comorbidities
Karmbir, Faisal, S. M., Narang, R. K., Kurmi, B. D., Kaur, K., & Sharma, A. K. (2026) · Inflammopharmacology · doi:10.1007/s10787-025-02027-y · Cited by 6
Thalén, D., Hellman, U., Wennerlund, J., Gunnarsson, U., Sundbom, M., & Strigård, K. (2026) · Obesity Surgery · doi:10.1007/s11695-026-08564-x · Cited by 3
Mihaila, D. F., Domnariu, H. P., Moga, D. F. C., & Domnariu, C. D. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15062257 · Cited by 3
Yan, J., Wang, J., Jian, F., Cui, X., Zhang, Y., Yang, X., Gao, Q., Ding, Z., 汤钊猷, Fan, J., et al. (2026) · Portal hypertension & cirrhosis · doi:10.1002/poh2.70033 · Cited by 7
Zhang, R., Li, K., Zhao, Z., Jiang, X., Zhang, R., Liu, C., Zhang, W., & Chen, S. (2026) · Targetome · doi:10.48130/targetome-0026-0012 · Cited by 3
Pavlov, C. S., Teplyuk, D. A., Лазебник, Л. Б., Аметов, А. С., Pashkova, E. Y., Sorokoletov, S. M., Uspenskiy, Y. P., Туркина, С. В., Ponomarenko, E. V., & Сергеевич, М. А. (2024) · Terapevticheskii arkhiv · doi:10.26442/00403660.2024.04.202747 · Cited by 3
Yang, K., Chung, B. S., & Ryu, T. (2024) · Nutrients · doi:10.3390/nu16152532 · Cited by 3
Zhao, M., Han, X., Fan, H. X., Liang, C., Wang, H., Zhang, X., Zhao, S., Guo, C., Liu, Z., & Zhang, T. (2024) · Liver International · doi:10.1111/liv.16136 · Cited by 4
Wu, Q., Peng, Y., & Gong, C. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2024.101759 · Cited by 3
Yousefi, F., Sponseller, B., Muyyarikkandy, M. S., Praveen, N., Greene, M. W., & Mooyottu, S. (2025) · npj gut and liver. · doi:10.1038/s44355-024-00016-6 · Cited by 3
Tanigawa, R., Nakajima, A., Eguchi, Y., Takahashi, H., Loomba, R. S., Suganami, H., Tanahashi, M., & Arai, H. (2025) · JCSM Communications · doi:10.1002/rco2.70002 · Cited by 3
Kelty, T. J., Krause, A. A., & Rector, R. S. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00178.2025 · Cited by 4
Romeo, M., Nardo, F. D., Napolitano, C., Basile, C., Palma, C., Vaia, P., Dallio, M., & Federico, A. (2025) · Diabetology · doi:10.3390/diabetology6080079 · Cited by 3
Hancock, M., Beyer, C., Fuchs, M., Harisinghani, M. G., Jalal, P. K., Ndaa, M., Samala, N. R., Vargas, J. D., & Jayaswal, A. N. A. (2025) · Journal of Medical Economics · doi:10.1080/13696998.2025.2550113 · Cited by 3
Frankovic, I., Djuricic, I. D., Ninić, A., Vekić, J., Vorkapic, T., Erceg, S., Gojković, T., Tomašević, R., Mamić, M., Mitrović, M., et al. (2024) · Biomolecules · doi:10.3390/biom14080902 · Cited by 4
Majeed, A. A., & Butt, A. S. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i1.100968 · Cited by 3
Fan, L., Zhu, X., Zhang, X., Salvador, S., Zhang, X., Shrubsole, M. J., Izzy, M. J., & Dai, Q. (2025) · Nutrients · doi:10.3390/nu17020244 · Cited by 8
Comi, L., Giglione, C., Klinaku, F. T., Dalt, L. D., Ullah, H., Daglia, M., & Magni, P. (2025) · Nutrients · doi:10.3390/nu17071249 · Cited by 4
Iancu, M., Coste, S. C., Cozma, A., Orasan, O. H., Lucaciu, R. L., Hangan, A. C., Para, I., Bogdan, S. G., & Procopciuc, L. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083730 · Cited by 3
Verrelli, N., Bonfiglio, C., Franco, I., Bagnato, C. B., Stabile, D., Shahini, E., & Bianco, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14113821 · Cited by 4
Li, T., Wang, Y., Zhao, S., Cui, Y., & Qu, Z. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70112 · Cited by 5
Chrysavgis, L., & Cholongitas, Ε. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21938-2.00020-5 · Cited by 3
Investigational new drug approval of DA-1241: what we know about GPR119 targeting for MASH therapy?
Smadi, K. A., Qureshi, A., Ashouri, B., & Kayali, Z. (2024) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2024.2388592 · Cited by 3
Stalin, A., Hesham, A. E., Mishra, A., Zou, Q., & Ignacimuthu, S. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1464176 · Cited by 3
Chronic liver disease after allogeneic hematopoietic cell transplantation
Randhawa, B., Blosser, N., Daly, A. S., Storek, J., Shaheen, A. A., & Jamani, K. (2024) · Cytotherapy · doi:10.1016/j.jcyt.2024.07.002 · Cited by 2
Tao, S., Guo, S., & Tong, N. (2024) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2952 · Cited by 2
Elmakki, E. E. (2024) · Cureus · doi:10.7759/cureus.66074 · Cited by 2
Zhu, Y., Chen, R., Han, H., Lin, X., & Shu, M. (2025) · Journal of Health Population and Nutrition · doi:10.1186/s41043-024-00714-0 · Cited by 2
The Epidemiology of Ascites in a Multi‐Ethnic Asian Population
Sinnanaidu, R. P., Poobalan, K., Singh, A. S. B., Nair, K., Vijayananthan, A., & Mahadeva, S. (2025) · JGH Open · doi:10.1002/jgh3.70111 · Cited by 2
Tada, T., Kumada, T., Gotoh, T., Niwa, F., Ogawa, S., Yasuda, S., Koshiyama, Y., Akita, T., Tanaka, J., Kodama, Y., et al. (2025) · Hepatology Research · doi:10.1111/hepr.14190 · Cited by 3
Moka, M. K., Rathakrishnan, D., Sriram, D. K., & George, M. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.03.024 · Cited by 2
Swaroop, S., Biswas, S., Mehta, S., Aggarwal, A., Arora, U., Agarwal, S., Chavan, A., Nayak, B., & Shalimar, S. (2025) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2025.102559 · Cited by 3
Zheng, K., Zhang, R., Xin, Y., Zhou, Y., Lin, J., Huang, W., Wang, F., Yang, L., Sun, X., & Kong, X. (2025) · Liver Research · doi:10.1016/j.livres.2025.04.004 · Cited by 2
Fernández‐Quintela, A., Santos, E. P. L., Portolés, T., Gual‐Grau, A., Sancho, J. V., & Portillo, M. P. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70078 · Cited by 3
Muto, H., Mizuno, F., Honda, T., Yokoyama, S., Tanaka, T., Yamamoto, K., Ito, T., Imai, N., Ishizu, Y., Sakai, K., et al. (2025) · Metabolites · doi:10.3390/metabo15060366 · Cited by 3
Helvacı, B. C., Tam, A. A., Erdoğan, B. T., Fakı, S., Çuhacı, F. N., Topaloğlu, O., Ersoy, R., & Çakır, B. (2025) · Archives of Medical Science · doi:10.5114/aoms/204182 · Cited by 2
Rehman, R. (2025) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v14.i3.105731 · Cited by 3
Yu, T., Xue, J., Tang, W., Wu, X., Li, J., Fan, Y., & Luo, L. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1563275 · Cited by 5
Pan-immune-inflammation value and mortality in the US adult MASLD: a nonlinear NHANES analysis
Zhou, Q., Xue, J., & Hao, L. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04064-x · Cited by 2
Lu, Y., Yuan, S., Xu, H., Ouyang, J., Dong, J., Jiang, X., Shao, X., & Zhang, R. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1571511 · Cited by 2
Liu, Z., Yin, H., Li, W., & Zhang, J. (2025) · Clinical and Translational Science · doi:10.1111/cts.70308 · Cited by 3
Doagoo, A., Ehtiati, S., Kachouei, R. A., Khatami, S. H., Rajaei, S., Jalilzadeh, M., Hamed, N. A., Namvarjah, F., Ahmadzade, R., Ajami, M., et al. (2025) · Journal of Food Biochemistry · doi:10.1155/jfbc/9463646 · Cited by 2
Lin, J., Green, V., Sohal, A., & Roytman, M. M. (2025) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002234 · Cited by 3
Gupta, P., Singh, S., Gulati, A., Dutta, N., Aggarwal, Y., Kalra, N., Premkumar, M., Taneja, S., Verma, N., De, A., et al. (2025) · Abdominal Radiology · doi:10.1007/s00261-025-05160-y · Cited by 6
Vats, K., & Alam, M. M. (2025) · Cureus · doi:10.7759/cureus.90268 · Cited by 6
Treatment Landscape of Metabolic-Dysfunction-Associated Steatotic Liver Disease
Patel, P. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14176060 · Cited by 7
Chen, X.-S., Liu, H., Huang, F., Meng, J., Fang, J.-X., Han, Y., Zou, H.-M., Gu, Q., Hu, X. F., Ma, Q.-W., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1623136 · Cited by 4
Even Lower Alcohol Intake Might Be Harmful for East Asian Males With MASLD Spectrum
Yun, B., Oh, J., Park, H., Lee, J., Kim, B. K., & Yoon, J. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2025.09.030 · Cited by 3
Ghusn, W., Sridharan, M., Fromer, R., Ozdemir, M., Haff, M. G., & Vargas, E. J. (2025) · Biomedicines · doi:10.3390/biomedicines13102437 · Cited by 2
Jia, J., Zhang, Y., Lin, J., Duan, Z., Chen, Y., & Zhang, X. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11102-0 · Cited by 3
Ehlers, L., Kasprick, A., Agrifoglio, O., Groß, N., Ernst, N., Gulde, A. B., Osterloh, C., Brauckmann, N. L., Fischer, N. Y., Bergmann‐Ewert, W., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1639622 · Cited by 3
Zhong, Q., Zhu, Y., Tan, Y., Deng, W., Wang, C., Yang, S., & Tong, N. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1664691 · Cited by 4
Shamsian, E., Bebawy, M., Israeli, Z., Mohsen, M., Karkra, R., Rella, S. C., Shankman, R., & Gaglio, P. J. (2025) · Livers · doi:10.3390/livers5040051 · Cited by 2
Niu, S., Chen, S., Wang, C., Yue, L., & Wang, S. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i10.110402 · Cited by 2
Elnasieh, A. M., Almesned, M., Alhazmi, A., Alturki, A. T., Alhawaidi, F. I., Alhadlq, R. K., Alramadhan, M., Alobilan, N., & Qroosh, Y. S. (2025) · JMIR Diabetes · doi:10.2196/77772 · Cited by 5
Tawfik, M. F., hussein, Y. S., Hasanin, A. H., Baher, W., El-Khazragy, N. N., Moawad, F. G., El-Khair, M. A., & El-Sayed, S. M. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04752-1 · Cited by 2
Zhang, S., Liang, H., Liu, J., & Zhu, Y. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-01039-3 · Cited by 3
Cho, H., Lee, B., Son, C., Choi, J., Eom, S., & Park, J. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112224 · Cited by 5
Kumar, G., Shah, Y. R., Shahzad, A., Jameel, K., Guevara-Lazo, D., Khan, N. A., Dahiya, D. S., Gangwani, M. K., Ravichandran, R., Patel, R. J., et al. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i11.111576 · Cited by 3
Uriostegui-Campos, M. A., Castro-Murrieta, S. A., Lopez-Cesati, X. I., Colín-Delgado, R., Carballo-López, G. I., Cervantes-Luévano, K., Moreno‐Ulloa, A., & Castro-Ceseña, A. B. (2025) · RSC Advances · doi:10.1039/d5ra06552f · Cited by 2
Ma, L., Wang, Y., Ren, T., Pan, L., Li, X., Wang, S., Li, D., Zhang, M., Li, F., Zheng, F. Y., et al. (2025) · Phytochemistry · doi:10.1016/j.phytochem.2025.114720 · Cited by 2
Association Between Subclinical Hypothyroidism and MASLD: A Systematic Review and Meta‐Analysis
Amdetsion, G. Y., Pan, C., Tebeje, H. G., Sapkota, A., Nandyal, S. R., & Kotwal, V. S. (2025) · International Journal of Hepatology · doi:10.1155/ijh/8133686 · Cited by 3
Highly Reproducible, Vendor‐Agnostic, Motion‐Insensitive Liver PDFF Mapping at 0.55T , 1.5T , and 3T
Tang, J., Tamada, D., Nielsen, J., Starekova, J., Heidenreich, J. F., Schön, F., Anagnostopoulos, A. A., Roshanshad, A., Mao, L., Fujita, S., et al. (2025) · Magnetic Resonance in Medicine · doi:10.1002/mrm.70223 · Cited by 3
Bazmi, S., Fardaei, M., Homayounfar, R., Kazemi, M., Pezeshki, B., Malekzadeh, R., Ghahramani, N., & Farjam, M. (2025) · European journal of medical research · doi:10.1186/s40001-025-03645-6 · Cited by 3
Wauquier, F., Chavanelle, V., Bouchard‐Mercier, A., Boutin-Wittrant, L., Otero, Y. F., Krisa, S., Valls, J., Joubioux, F. L., Pereira, B., Roux, V., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-32556-z · Cited by 3
Saeed, Z. I., & Apovian, C. M. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01369-w · Cited by 2
Piana, K., Ziomber-Lisiak, A., & Szczerbowska‐Boruchowska, M. (2026) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2025.127428 · Cited by 2
Zhan, F., 陈添彬, Liang, J., Liu, C., Huang, M., & Jiang, L. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.120831 · Cited by 2
Silvares, R. R., de Araujo, B. P., Pereira, E. N. G. D. S., Rodrigues, K. L., Barbosa, J. M. C., da Silva, J. F., Silva, V. V. D. D., de aarenburg, M. V., Scheijen, J. L. J. M., Wouters, K., et al. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2025.1736221 · Cited by 2
Huang, Y.-C., Hsu, J., Wang, C.-L., Kao, Y.-C., Lai, C.-Y., Chen, H.-W., & Wu, L.-L. (2026) · BMC Nephrology · doi:10.1186/s12882-026-04840-1 · Cited by 2
Advances in the Pharmacologic Management of MASLD
Madhankumar, S., & Asma, A. (2026) · Gastroenterology Insights · doi:10.3390/gastroent17010017 · Cited by 2
Pesticides Drive Liver Diseases Through Non-Apoptotic Regulated Cell Death Pathways
Khairullina, Z. S., Kurmangaliyeva, S. S., Yussupov, R., Kelimberdiyeva, E., Tryfonyuk, L., Shapambayev, N., Seidakhmetova, A., Medetbekov, T., & Tkachenko, A. (2026) · Diseases · doi:10.3390/diseases14030096 · Cited by 3
Mihaila, D. F., Domnariu, H. P., Moga, D. F. C., & Domnariu, C. D. (2026) · Metabolites · doi:10.3390/metabo16040224 · Cited by 2
Chen, D., Yan, L., Wu, T., Zhao, J., Xu, X., Xu, W., Zhang, H., & Xiao, M. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1819756 · Cited by 3
Moslehi, N., Hosseinpanah, F., Mirmiran, P., & Azizi, F. (2026) · Nutrition & Metabolism · doi:10.1186/s12986-026-01106-3 · Cited by 2
Üçgül, E., Menekşe, B., Cankaya, R., Görgülü, M., Uçan, B., Çakal, E., & Kızılgül, M. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1790066 · Cited by 2
Kim, J., Yoo, S.-H., Yoo, Y., & Lee, B.-C. (2026) · Biomolecules · doi:10.3390/biom16050651 · Cited by 3
Roy, T., Ray, A. G., Pratihar, S., Sarkar, S., Sinha, S., Alam, M. J., Mabalirajan, U., & Bandyopadhyay, A. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.120764 · Cited by 2
Basta, D., Refaei, A. H. A., Msinjili, L., Frishman, W. H., & Lebovics, E. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001298 · Cited by 3
Degrave, V. M., Ingaramo, P. I., Caltana, L. R., Sedán, D., Andrinolo, D., D’Alessandro, M. E., & Oliva, M. E. (2026) · Medical Cannabis and Cannabinoids · doi:10.1159/000552533 · Cited by 2
Nageswaran, G., Chidambaram, V., Kumar, A., Doukky, R., Leucker, T. M., Al'Aref, S., & Thandassery, R. B. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156723 · Cited by 1
Bentsa, T. М. (2023) · Modern Gastroenterology · doi:10.30978/mg-2023-6-59 · Cited by 3
Campos-Espinosa, A., Guzmán, C., Medina-Ávila, K. Z., & Gutiérrez‐Reyes, G. (2024) · Cells · doi:10.3390/cells13030282 · Cited by 3
Esparham, A., Shoar, S., Mehri, A., Khorgami, Z., & Modukuru, V. R. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07238-w · Cited by 4
Mostovyi, S. Y., Zhaivoronok, M., & Safonova, O. M. (2024) · GASTROENTEROLOGY · doi:10.22141/2308-2097.58.2.2024.601 · Cited by 3
Navarro‐Masip, È., Petit, N. M., Salinas‐Roca, B., Herrerías, F., Vilardell, F., de la Fuente, M. C., Pallarés, J., Santamaría, M., Zorzano-Martínez, M., Sánchez, E., et al. (2024) · Obesity Facts · doi:10.1159/000538765 · Cited by 5
Ye, D., Wang, J., Shi, J., Ma, Y., Chen, J., Hu, X., & Bao, Z. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02245-3 · Cited by 3
Metadata
- Authors
- Chan, W.-K., Chuah, K.-H., Rajaram, R. B., Lim, L.-L., Ratnasingam, J., & Vethakkan, S. R.
- Affiliations
- University of Malaya (MY)
- Chinese University of Hong Kong (HK)
- Corresponding author
- Chan, Wah-Kheong
- Venue
- Journal of Obesity & Metabolic Syndrome
- Published
- 2023-09-13
- Volume
- 32
- Issue
- 3
- Pages
- 197-213
- ISSN
- 2508-6235 (ISSN-L)
- 2508-7576
- PMC
- PMC10583766
- OpenAlex
- W4386704735
- Cited by
- 776
- References
- 122
- Citations by year
- 2026: 245 · 2025: 342 · 2024: 183 · 2023: 5
- FWCI
- 30.29
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0/ (tdm)
- Locations
- Journal of Obesity & Metabolic Syndrome (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- non-alcoholic fatty liver disease, metabolic syndrome, obesity, chronic liver disease, non-invasive liver assessment, referral pathways, lifestyle intervention, cardiovascular risk, anti-hyperglycemic drugs, liver cirrhosis, decompensated cirrhosis, compensated advanced chronic liver disease, clinically significant portal hypertension, sarcopenia, liver complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.